Phase 2 study of pegylated liposomal doxorubicin, vincristine, decreased-frequency dexamethasone, and thalidomide in newly diagnosed and relapsed-refractory multiple myeloma (Q79887297)
scientific article published on 01 July 2006
Language:
(P31) (Q13442814)
(P304) 889-895
(P433) 7
(P478) 81
(P577) Saturday, July 1, 2006
(P921) (Q422252)
(Q467635)
(Q18936)
(P1433) (Q6538184)
(P1476) "Phase 2 study of pegylated liposomal doxorubicin, vincristine, decreased-frequency dexamethasone, and thalidomide in newly diagnosed and relapsed-refractory multiple myeloma" (language: en)
(P2093) Mohamad A Hussein
Rachid Baz
Gordan Srkalovic
Neeraj Agrawal
Revathi Suppiah
Eric Hsi
Steven Andresen
Mary Ann Karam
Janice Reed
Beth Faiman
Megan Kelly
Esteban Walker
other details
description scientific article published on 01 July 2006

External Links